Skip to main content
Full access
Letter to the Editor
Published Online: 1 April 2005

Mania in a Boy Treated With Modafinil for Narcolepsy

Publication: American Journal of Psychiatry
To the Editor: Modafinil is the first-line treatment for narcolepsy. It may also improve mood in narcoleptic patients (1). However, psychostimulants may exacerbate psychotic symptoms in psychotic patients (2). Cases of psychosis have also been reported during psychostimulant abuse (3) and during abuse of prescribed drug in narcoleptic patients (4) but not following medical use. Here we report the case of a boy with narcolepsy.
Albert was a 17-year-old boy who was diagnosed with narcolepsy at age 14. He was first prescribed modafinil, 400 mg/day for 1 year, switched to methylphenidate, 40 mg/day for 2 years, then returned to modafinil, 400 mg/day. The switching was because of complaints of irritability and of a lack of efficacy for sleep attacks. Albert then experienced flight of ideas, sexual excitation, and increased irritability. These manic symptoms resulted in friction with family members and a fight for which he could have been put on trial. Then, free of psychostimulant treatment, Albert was described as sad, anhedonic, and withdrawn. Following reintroduction of modafinil, the same manic symptoms reoccurred. After a meeting with a judge, Albert experienced self-referential thinking and suspiciousness. Later, a full manic episode developed within 3 days, including insomnia, tachypsychia, logorrhea, psychomotor agitation, and mood-incongruent psychosis. There was no grandiosity but delusion of persecution, based on auditory hallucinations (his uncle reproaching him for his past sexual behavior), complex visual hallucinations (a vampire hiding in his bedroom and trying to bite him), and a feeling of being talked to through the television. Albert was hospitalized, and the modafinil was stopped. The mania required pharmacological treatment that started after written consent was obtained from both Albert and his parents.
These mood symptoms seem time-related to psychostimulant administration and interruption. Exposure lasted for only 3 years, but discontinuation and reintroduction might have lowered the manic threshold. Contrary to previous reports of psychosis induced by psychostimulant abuse (3), the patient showed no trend toward dose escalation. This could be the first report of mania under a therapeutic dose of modafinil. The symptoms were compatible with psychostimulant-induced psychosis. Although an independent psychiatric disorder cannot be ruled out, we suggest a careful psychiatric monitoring of patients receiving modafinil and other psychostimulants for the treatment of narcolepsy.

References

1.
Becker PM, Schwartz JR, Feldman NT, Hughes RJ: Effect of modafinil on fatigue, mood, and health-related quality of life in patients with narcolepsy. Psychopharmacology (Berl) 2004; 171:133–139
2.
Narendran R, Young CM, Valenti AM, Nickolova MK, Pristach CA: Is psychosis exacerbated by modafinil? (letter). Arch Gen Psychiatry 2002; 59:292–293
3.
Spensley J, Rockwell DA: Psychosis during methylphenidate abuse. N Engl J Med 1972; 286:880–881
4.
Leong GB, Shaner AL, Silva JA: Narcolepsy, paranoid psychosis, and analeptic abuse. Psychiatr J Univ Ott 1989; 14:481–483

Information & Authors

Information

Published In

Go to American Journal of Psychiatry
Go to American Journal of Psychiatry
American Journal of Psychiatry
Pages: 813-a - 814

History

Published online: 1 April 2005
Published in print: April 2005

Authors

Affiliations

FLORENCE VORSPAN, M.D.
DOMINIQUE WAROT, M.D., Ph.D.
DAVID COHEN, M.D., Ph.D.
PHILIPPE MAZET, M.D.
Paris, France

Metrics & Citations

Metrics

Citations

Export Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.

For more information or tips please see 'Downloading to a citation manager' in the Help menu.

Format
Citation style
Style
Copy to clipboard

There are no citations for this item

View Options

View options

PDF/ePub

View PDF/ePub

Get Access

Login options

Already a subscriber? Access your subscription through your login credentials or your institution for full access to this article.

Personal login Institutional Login Open Athens login
Purchase Options

Purchase this article to access the full text.

PPV Articles - American Journal of Psychiatry

PPV Articles - American Journal of Psychiatry

Not a subscriber?

Subscribe Now / Learn More

PsychiatryOnline subscription options offer access to the DSM-5-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).

Media

Figures

Other

Tables

Share

Share

Share article link

Share